Arkolith/Insider Trading/ZBIO/Form 4

Fox Jennifer A.

See RemarksZenas BioPharma, Inc. (ZBIO) · full profile →Form 4 · filed Jun 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2026Grant(A)2K$13.35$21K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Grant(A)125K—$0125K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-075249) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML